DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Chembio Diagnostics Q4 EPS $(0.23) Beats $(0.24) Estimate, Sales $6.9M Miss $8.55M Estimate

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 9.52 percent decrease over losses of $(0.21) per share from

Benzinga · 03/12/2020 20:31

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 9.52 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $6.9 million which missed the analyst consensus estimate of $8.55 million by 19.30 percent. This is a 9.15 percent decrease over sales of $7.595 million the same period last year.